Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
DiamPark is a digital follow-up ecosystem for Parkinson’s disease developed by France-based DiamPark SAS. Its core components are the patient-facing Digipark App and the healthcare professional platform Digipark 360. It is not a general-purpose enterprise SaaS product, but a disease-specific management platform with medical device attributes. Its goal is to structure medication use, symptom fluctuations, activity, and wearable data between clinic visits, supporting both patient self-management and doctors’ clinical review.
The patient app covers smart pillbox support, personalized medication reminders, adherence tracking, symptom diaries, assessments for mood, sleep, pain, and mobility, rehabilitation exercises, and treatment education. A notable feature is its use of four categories of digital biomarkers: typing, tremor, voice, and handwriting. It can also collect activity, passive tremor, and sleep quality data through a smartwatch. The professional platform, Digipark 360, provides patient dashboards, 3/6/12-month longitudinal trends, clinical summaries, PDF reports, and fluctuation alerts. It also supports secure sharing among medical teams, making it suitable for collaboration across neurology, multidisciplinary rehabilitation, and home healthcare services.
The text clearly states that the patient app is available for free on iOS and Android. It can be used independently or connected to a healthcare professional’s Digipark 360 account. Plans, pricing, trials, and payment methods for the professional platform are not disclosed. Security and compliance are a major focus: DiamPark states that it complies with GDPR, that health data is hosted by an HDS-certified provider, that it follows ANS recommendations, and that it has obtained CE Class I medical device marking. The deployment model appears to be a cloud platform plus mobile apps, with no visible information on self-hosting, private deployment, or open APIs.
Its strengths are its deep focus on a vertical medical scenario, strong emphasis on patient-side usability, and structured longitudinal data that is useful for clinicians. Its medical compliance information is also relatively complete. The drawbacks are limited transparency around the professional platform’s commercial offering, and a lack of details on third-party HIS/EMR integrations, APIs, and permissions. Apple Watch support also still appears to be listed as coming soon. DiamPark is best suited for Parkinson’s patients, caregivers, neurologists, rehabilitation teams, and organizations conducting disease-specific follow-up or research.
Its accessibility from China cannot be determined from the text. Since the product is designed for the French/EU medical compliance framework, deployment in Chinese hospitals would require further assessment of network connectivity, cross-border data transfer, medical device requirements, personal information protection rules, and availability through the App Store or Google Play. In China, possible alternatives include hospital follow-up systems, chronic disease management platforms from internet hospitals, or local wearable-based health monitoring solutions.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on diampark.io official site.
diampark.io is an France SaaS provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach diampark.io directly.